FAS Monoclonal Antibody

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains a death domain. It has been shown to play a central role in the physiological regulation of programmed cell death, and has been implicated in the pathogenesis of various malignancies and diseases of the immune system. The interaction of this receptor with its ligand allows the formation of a death-inducing signaling complex that includes Fas-associated death domain protein (FADD), caspase 8, and caspase 10. The autoproteolytic processing of the caspases in the complex triggers a downstream caspase cascade, and leads to apoptosis. This receptor has been also shown to activate NF-kappaB, MAPK3/ERK1, and MAPK8/JNK, and is found to be involved in transducing the proliferating signals in normal diploid fibroblast and T cells. Several alternatively spliced transcript variants have been described, s

Introducing the FAS Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunology. This meticulously crafted antibody is specifically engineered to target and bind to the FAS receptor, a key player in the regulation of programmed cell death.

With its exceptional specificity and high affinity, the FAS Monoclonal Antibody offers unparalleled precision in detecting and neutralizing FAS receptor activity. Its monoclonal nature ensures consistent and reliable performance, making it an indispensable tool for researchers and clinicians alike.

The FAS Monoclonal Antibody's advanced formulation guarantees optimal stability and longevity, enabling prolonged usage without compromising its efficacy. Its robust design allows for seamless integration into various experimental protocols, facilitating comprehensive investigations into FAS-mediated signaling pathways and associated cellular processes.

This groundbreaking product holds immense potential in elucidating the intricate mechanisms underlying immune responses, cancer development, and autoimmune disorders. By providing a means to selectively modulate FAS receptor function, the FAS Monoclonal Antibody opens up new avenues for therapeutic interventions and the development of novel treatment strategies.

In summary, the FAS Monoclonal Antibody represents a remarkable advancement in immunological research, offering unparalleled specificity, reliability, and versatility. With its potential to unravel the complexities of FAS-mediated signaling, this product is poised to revolutionize the understanding and treatment of various diseases. Embrace the future of immunology with the FAS Monoclonal Antibody.